FDA Inspection 1327022 - Octapharma Plasma Inc - July 10, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Octapharma Plasma Inc

Record Details

This FDA Inspection record concerns Octapharma Plasma Inc, with an inspection on July 10, 2026, issued by the New Jersey District Office, covering biologics.

Company: Octapharma Plasma Inc
Inspection Date: July 10, 2026
Product Type: Biologics
Office: New Jersey District Office

Open in Dashboard

ID · e00e4431-7140-48fe-841b-189d5fcd5fe4

Violation Codes1

21 CFR 606.20(b)

Full citation text and observation details available on the Dashboard.